Prudential Financial Inc Cytom X Therapeutics, Inc. Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

A detailed history of Prudential Financial Inc transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 36,500 shares of CTMX stock, worth $38,690. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,500

Previous 36,500 -0.0%

Holding current value

$38,690

Previous $44,000 2.27%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.21 - $5.13 $5,566 - $23,598	4,600 Added 14.42%	36,500 $44,000
Q1 2024 May 14, 2024	BUY	$1.41 - $2.74 $21,996 - $42,744	15,600 Added 95.71%	31,900 $69,000
Q3 2023 Nov 13, 2023	SELL	$1.26 - $1.87 $10,584 - $15,708	-8,400 Reduced 34.01%	16,300 $21,000
Q2 2023 Aug 11, 2023	SELL	$1.41 - $1.92 $3,384 - $4,608	-2,400 Reduced 8.86%	24,700 $42,000
Q3 2022 Nov 04, 2022	BUY	$1.23 - $1.97 $9,102 - $14,578	7,400 Added 37.56%	27,100 $39,000
Q2 2022 Aug 15, 2022	BUY	$1.53 - $2.89 $30,141 - $56,933	19,700 New	19,700 $36,000
Q1 2021 May 12, 2021	SELL	$6.6 - $9.0 $548,064 - $747,360	-83,040 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$6.47 - $7.9 $471,663 - $575,910	-72,900 Reduced 46.75%	83,040 $544,000
Q3 2020 Nov 16, 2020	SELL	$6.55 - $8.83 $590,999 - $796,722	-90,229 Reduced 36.65%	155,940 $1.04 Million
Q2 2020 Aug 12, 2020	SELL	$7.4 - $14.64 $716,630 - $1.42 Million	-96,842 Reduced 28.23%	246,169 $2.05 Million
Q1 2020 May 12, 2020	SELL	$3.61 - $8.6 $426,467 - $1.02 Million	-118,135 Reduced 25.62%	343,011 $2.63 Million
Q4 2019 Feb 11, 2020	BUY	$5.17 - $8.91 $1,778 - $3,065	344 Added 0.07%	461,146 $3.83 Million
Q3 2019 Nov 13, 2019	BUY	$7.38 - $12.25 $1.66 Million - $2.76 Million	225,530 Added 95.86%	460,802 $3.4 Million
Q2 2019 Aug 08, 2019	BUY	$9.35 - $11.41 $1.37 Million - $1.67 Million	146,647 Added 165.47%	235,272 $0
Q1 2019 May 15, 2019	BUY	$9.5 - $19.16 $564,442 - $1.14 Million	59,415 Added 203.41%	88,625 $0
Q4 2017 Feb 13, 2018	BUY	$19.0 - $23.09 $554,990 - $674,458	29,210	29,210 $617,000

Others Institutions Holding CTMX

# of Institutions

Shares Held

50.7M

Call Options Held

112K

Put Options Held

8.3K

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Cytom X Therapeutics, Inc. Transaction History